General MedicationsORALStandard

LOXAPINE SUCCINATE

Standard Dose

EQ 25MG BASE

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Prescription

Summary

Approval overview LOXAPINE SUCCINATE is listed in Drugs@FDA under application 090695 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient LOXAPINE SUCCINATE Form and strength CAPSULE;ORAL - EQ 25MG BASE Sponsor LANNETT CO INC Submission history Latest submission status date: 2025-01-22 00:00:00.

Structured Monograph

Clinical summary

Approval overview LOXAPINE SUCCINATE is listed in Drugs@FDA under application 090695 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient LOXAPINE SUCCINATE Form and strength CAPSULE;ORAL - EQ 25MG BASE Sponsor LANNETT CO INC Submission history Latest submission status date: 2025-01-22 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Prescription
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.